Raloxifene: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page) |
(No difference)
|
Revision as of 17:32, 14 July 2010
In pharmacology, raloxifene is "a second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue."[1]
References
- ↑ Anonymous (2024), Raloxifene (English). Medical Subject Headings. U.S. National Library of Medicine.